drug

lenvatinib

1 story · latest Sep 24, 2026

Status: FDA approved Feb 2015 · NDA206947
Brand: Lenvima
Trials: 5 registered trials in coverage

Relationships

Developed by Eisai

Timeline

FDA approves supplement 35 for Eisai's Lenvima

Sep 24Regulatory decisionEisai lenvatinib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.